Graybug Vision, Inc.
Graybug Vision, Inc. (GRAY) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GRAY · as of Dec 31, 2022
Ownership Breakdown
30
Institutional Holders
▲ 8 vs Q3
$5.97M
Total Inst. Value
▼ $4.20M vs Q3
22.00M
Shares Outstanding
freeFloat 46.91%
11.95M
13F Shares Held
▲ 1.12M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GRAY largest shareholders · institutional ownership
Q4 2022 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CUTLER GROUP LLC / CA pharmaceutical preparations | 200 | 2.43% | 2.43% | $0 | Feb 7, 2023 | — held |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 5.28M | 0.67% | 0.67% | $2.64B | Feb 14, 2023 | — held |
ORBIMED ADVISORS LLC pharmaceutical preparations | 4.16M | 0.53% | 0.53% | $2.08B | Feb 14, 2023 | — held |
SIMPLEX TRADING, LLC pharmaceutical preparations | 17 | 0.21% | 0.21% | $0 | Feb 2, 2023 | ▼ 949 |
BML CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.24M | 0.16% | 0.16% | $617.97M | Feb 13, 2023 | NEW |
VANGUARD GROUP INC pharmaceutical preparations | 419.9K | 0.05% | 0.05% | $209.96M | Feb 10, 2023 | ▲ 179 |
FIRST MANHATTAN CO. LLC. pharmaceutical preparations | 271.3K | 0.03% | 0.03% | $135.67M | Feb 14, 2023 | ▼ 20.7K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 156.0K | 0.02% | 0.02% | $78.00M | Feb 13, 2023 | ▼ 44.5K |
BANK OF NEW YORK MELLON CORP pharmaceutical preparations | 100.2K | 0.01% | 0.01% | $50.11M | Feb 14, 2023 | ▼ 755 |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 66.2K | 0.01% | 0.01% | $33.00M | Feb 13, 2023 | ▼ 179 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2022 vs prior quarter
Q4 2022
4
Increased
+7.5K shares8
New Positions
first time holders9
Decreased
−131.1K shares4
Sold Out
fully exitedNet shares change (top 50)
123.6K
+7.5K / −131.1K
Net new holders
-1
8 new / 4 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GRAY insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
WILSON ROBERT N director | Dec 11, 2023 | Purchase | 506 | $3.30 | $1.7K | 182.2K | Form 4 ↗ |
Leheny A. Rachel Chief Executive Officer | Nov 7, 2023 | Purchase | 2,000 | $3.34 | $6.7K | 18.8K | Form 4 ↗ |
Roberts Eric W Chief Business Officer | Nov 6, 2023 | Purchase | 2,400 | $3.12 | $7.5K | 35.9K | Form 4 ↗ |
Roberts Eric W Chief Business Officer | Nov 3, 2023 | Purchase | 11,249 | $2.83 | $31.8K | 33.5K | Form 4 ↗ |
Roberts Eric W Chief Business Officer | Nov 3, 2023 | Purchase | 3,700 | $2.77 | $10.2K | 20.3K | Form 4 ↗ |
Leheny A. Rachel Chief Executive Officer | Nov 6, 2023 | Purchase | 2,440 | $3.12 | $7.6K | 16.8K | Form 4 ↗ |
Hebbar Sudarshan Chief Medical Officer | Nov 3, 2023 | Purchase | 36,000 | $2.74 | $98.6K | 46.0K | Form 4 ↗ |
Roberts Eric W Chief Business Officer | Nov 3, 2023 | Purchase | 5,860 | $2.70 | $15.8K | 22.2K | Form 4 ↗ |
Roberts Eric W Chief Business Officer | Nov 3, 2023 | Purchase | 3,200 | $2.80 | $9.0K | 16.6K | Form 4 ↗ |
Leheny A. Rachel Chief Executive Officer | Nov 3, 2023 | Purchase | 5,000 | $2.85 | $14.3K | 14.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Graybug Vision, Inc. (GRAY) is primarily owned by institutional investors, who hold approximately 54.3% of total shares outstanding. Company insiders own approximately 53.09%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Graybug Vision, Inc. is CUTLER GROUP LLC / CA, holding approximately 200 shares — equal to 2.43% of outstanding shares — as of December 31, 2022.
A total of 30 institutional investors currently hold GRAY stock, with a combined institutional value of approximately $5,974,899 as of the most recent 13F filing period.
Frequently asked questions
GRAY ownershipGraybug Vision, Inc. (GRAY) is primarily owned by institutional investors, who hold approximately 54.3% of shares. The largest shareholder is CUTLER GROUP LLC / CA with a 2.43% stake. Company insiders hold 53.09%. Data sourced from SEC Form 13F as of December 31, 2022.